GH Guardant Health, Inc.

NEUTRAL Impact: 3/10 Insider Cluster (5 insiders)
Horizon days Filed May 28, 2026 Processed 9d 2h ago
Insider cluster: 5 insiders, $5.0M total

Price Chart

Loading chart...

Executive Summary

A cluster of insider sales at Guardant Health totaling $5.01M over a 7-day window, led by the Chief Commercial Officer ($2.90M) and Chief Legal Officer ($1.25M), represents approximately 0.03% of the $16.9B market cap. While the dollar amount is trivial relative to company size, the cluster includes C-suite executives and coincides with derivative exercises by Freeman, suggesting liquidity-driven selling rather than a bearish signal. The stock has strong analyst support (88% bullish) and the historical calibration shows cluster-insider-trades as an amplifier, but the proportionality check keeps this as a low-impact event.

Key Financial Metrics

Direction
selling
Total Value
$5.0M
Insiders
5

Actionable Insight

The cluster is too small relative to market cap to warrant a bearish read-through. Freeman's sale coincides with a derivative exercise, indicating tax/vesting-related liquidity rather than informed selling. Monitor next earnings for fundamental trends, but this filing alone does not signal deterioration.

Key Facts

  • 5 insiders sold shares totaling $5.01M over May 20-27, 2026
  • Chief Commercial Officer Chris Freeman sold $2.90M after exercising derivatives at $32.86/share
  • Chief Legal Officer John Saia sold $1.25M at $125.08/share
  • Total sales represent ~0.03% of Guardant Health's $16.9B market cap
  • Freeman's derivative exercise (24,406 shares at $32.86) was a non-cash event paired with an open-market sale
  • Analyst consensus is 88% bullish (29 Buy/Strong Buy, 4 Hold)

Financial Impact

Total insider sales of $5.01M, or 0.03% of market cap — immaterial relative to company size

insider ownership

Risk Factors

  • If future insider sales accelerate in dollar volume or involve additional C-suite members without derivative exercises, the signal would strengthen
  • The stock's strong run (up ~44% in 30 days per prior report) may have prompted routine portfolio rebalancing

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
88% bullish (33 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GH-1780007590777
14 reports for GH
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+1▲ +4.43%May 27, 2026
Filters
Rows
Reports for GH — sortable, filterable
Type Now
Jun 5, 2026
1d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 4, 2026
2d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 29, 2026
8d ago
Insider Cluster
NEUTRAL ★ 2/10
$128.42 $130.17▲ +1.36%▲ +1.21%$125.61 (−2.19%)
May 29, 2026
8d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 28, 2026
9d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 27, 2026
11d ago
Court Ruling
BULLISH ★ 6/10
$127.45 $133.09▲ +4.43%▲ +3.87%$125.61 (−1.45%)
May 26, 2026
11d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
May 22, 2026
15d ago
144
BEARISH ★ 5/10
$119.29 $127.45▼ −6.84%▼ −6.83%$125.61 (−5.29%)
May 22, 2026
15d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
May 22, 2026
15d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (11h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access